Hwg Holdings LP Dexcom Inc Transaction History

Hwg Holdings LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $11,134 - $12,967	99 New	99 $12,000
Q3 2022 Nov 09, 2022	SELL	$76.35 - $94.18 $763 - $941	-10 Closed	0 $0
Q1 2022 Apr 26, 2022	BUY	$94.08 - $130.2 $940 - $1,302	10 New	10 $5,000
Q4 2020 Jan 20, 2021	SELL	$78.0 - $104.5 $673,998 - $902,984	-8,641 Closed	0 $0
Q3 2020 Oct 02, 2020	BUY	$95.51 - $112.95 $263,416 - $311,516	2,758 Added 46.88%	8,641 $3.56 Million
Q2 2020 Aug 17, 2020	BUY	$62.68 - $105.34 $48,514 - $81,533	774 Added 15.15%	5,883 $2.39 Million
Q4 2019 Jan 09, 2020	BUY	$36.62 - $57.29 $148,054 - $231,623	4,043 Added 379.27%	5,109 $1.12 Million
Q3 2019 Nov 20, 2019	BUY	$35.53 - $43.8 $532 - $657	15 Added 1.43%	1,066 $159,000
Q2 2019 Jul 29, 2019	BUY	$27.84 - $38.92 $29,259 - $40,904	1,051 New	1,051 $157,000

1,084

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Hwg Holdings LP, based on Form 13F filings with the SEC.

Stay updated on Hwg Holdings LP with notifications on news.